Genentech – Uniting Bay Area Communities in Addressing Childhood Adversity
Rajni Dronamraju, Senior Director, Charitable Giving Strategy at Genentech, discusses Genentech’s ongoing efforts to address the impact of trauma, stress and racism on the health and well-being of low-income kids and families across the Bay Area. She also discusses the recent launch of the All In For Kids multi-donor fund to unite Bay Area nonprofits, advocates and leaders in advancing solutions that address childhood adversity and trauma. Genentech seeded the fund with $5M. Listeners can learn more at The Resilience Effect.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Rajni Dronamraju, Senior Director, Charitable Giving Strategy at Genentech, discusses Genentech’s ongoing efforts to address the impact of trauma, stress and racism on the hea…
- Key Point: She also discusses the recent launch of the All In For Kids multi-donor fund to unite Bay Area nonprofits, advocates and leaders in advancing solutions that address childhood ad…
- Key Point: Listeners can learn more at The Resilience Effect.
- Key Point: As the Senior Director of Charitable Giving Strategy at Genentech, Rajni oversees the company wide charitable giving portfolio, including more than $50M per year in strategic fu…
- Key Point: Over the past four years, Rajni led the creation and launch of The Resilience Effect, Genentech’s first major philanthropic investment in health equity.
As the Senior Director of Charitable Giving Strategy at Genentech, Rajni oversees the company wide charitable giving portfolio, including more than $50M per year in strategic funding aimed at advancing health equity and building diverse and inclusive careers in the life sciences. Over the past four years, Rajni led the creation and launch of The Resilience Effect, Genentech’s first major philanthropic investment in health equity. The initiative now represents a $20M+ investment to improve the health and wellbeing of Bay Area children and families affected by trauma, and has catalyzed significant public and private investment statewide. Signature investments include the Resilient Beginnings Network, an initiative to improve pediatric care for over 75,000 low-income kids and families, and All in for Kids, a multi-donor initiative to prevent childhood trauma and exposure to domestic violence. Prior to Genentech, Rajni spent five years at FSG, where she advised organizations such as Toyota Mobility Foundation, Coca-Cola Brazil, Eli Lilly and Company, the Lego Foundation, and others on their philanthropic and social responsibility strategies and programs. Rajni holds a bachelor’s degree in Political Science and International Studies from Northwestern University, and a master’s degree in International Development Management from the London School of Economics and Political Science.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



